The Patent Finder

Oncoquest Pharmaceuticals Inc.

Also on record
Records under this name other than patents Oncoquest Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Oncoquest Pharmaceuticals Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,697,079Ige Antibodies for the Treatment of Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,945,566METHODS FOR IMPROVING THE BIOACTIVITY OF THERAPEUTIC IgE ANTIBODIES FOR THE TREATMENT OF DISEASE
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,392,444Tumor antigen specific antibodies and TLR3 stimulation to enhance the performance of checkpoint interference therapy of cancer
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,975,163Methods of increasing delivery of anti-cancer agents to targets
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,537,636Treatment of Cancer with Therapeutic Monoclonal Antibody Specific for a Tumor Associated Antigen and an Immune Adjuvant
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,351,255Treatment of Cancer with Therapeutic Monoclonal Antibody Specific for a Tumor Associated Antigen and an Immune Adjuvant
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,147,850Therapeutic Binding Agents Against MUC-1 Antigen and Methods for Their Use
Formerly held
Term ended
Ended no later than Oct 13, 2021 · Low confidence
Term endedEnded no later than Oct 13, 2021Low confidence
US 6,689,355Therapeutic Method and Composition Utilizing Antigen-Antibody Complexation and Presentation by Dendritic Cells
Formerly held
Term ended
Term ended May 11, 2021 · High confidence
Term endedTerm ended May 11, 2021High confidence
US 8,038,994Combination therapy for treating disease
Formerly held
Term ended
Term ended Apr 2, 2021 · USPTO record
Term endedTerm ended Apr 2, 2021USPTO record
US 6,716,966Therapeutic binding agents against MUC-1 antigen and methods for their use
Formerly held
Term ended
Term ended Aug 18, 2020 · USPTO record
Term endedTerm ended Aug 18, 2020USPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited